# Citius Oncology, Inc.: Form SCHEDULE 13D/A, filed Jun 4, 2026

- Company: [Citius Oncology, Inc.](/companies/ctor.md) (CIK 1851484)
- Form: SCHEDULE 13D/A
- Filed: 2026-06-04
- Accepted by EDGAR: Jun 4, 2026, 16:30 ET
- Period: not reported
- Accession: 0001213900-26-065310
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1851484/000121390026065310/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1851484/000121390026065310/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1851484/000121390026065310/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jun 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-065310. Last ingested by Listed: Nov 4, 2026, 17:46 ET. No prices; not investment advice.